Medical Condition News

RSS

Common antidepressant Fluoxetine protects from sepsis-induced death

...

19 Feb 2025

Preventing colorectal cancer through lifestyle choices

The evidence is clear - screening for colorectal cancer may save one's life. Today, more and more people are choosing colorectal cancer screening. As a result, there is a steady decline in the number of older people getting and dying from colorectal cancer. Lower rates of smoking among Americans have also contributed to the decline in the past several years.

19 Feb 2025

Study shows promise for new treatment approach for multiple sclerosis

A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave University of Michigan researchers a first look at how primary progressive multiple sclerosis, the fastest-progressing version of the disease, attacks the central nervous system early on.

19 Feb 2025

Lasting impact of long COVID and the protective benefits of vaccination

Researchers explore the mental and physical health outcomes in patients with long COVID.

19 Feb 2025

Recreational exercise, not work activity, linked to lower type 2 diabetes risk

Researchers have found that engaging in moderate to vigorous physical activity during leisure time, regardless of occupational physical activity, is associated with a reduced risk of type 2 diabetes. A combination of sedentary leisure-time activity and demanding occupational activity may increase the risk.

19 Feb 2025

New study reveals LRP1's crucial role in bone formation and joint development

Skeletal conditions such as developmental dysplasia of the hip (DDH), osteoporosis, and osteoarthritis affect millions worldwide, often causing chronic pain and disability. These disorders stem from complex genetic and environmental interactions that disrupt bone formation and joint development.

19 Feb 2025

Nerinetide shows promise in stroke treatment meta-analysis

The Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, has been involved with three papers published this week in The Lancet and Lancet Neurology-the ESCAPE-NEXT trial, the FRONTIER trial, and an individual patient-level meta-analysis across three trials.

19 Feb 2025

Drinking more water may lower heart disease risk, but too much coffee and tea could raise it

Drinking water may help reduce cardiovascular disease (CVD) risk, while excessive coffee and tea intake (≥6 cups/day) increases the likelihood of CVD, with stronger effects in women.

19 Feb 2025

Novel therapeutic approaches targeting the Wnt pathway in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the deadliest cancers globally, with increasing incidence and mortality rates.

19 Feb 2025

Study suggests taxifolin could be a safe, natural way to aid weight loss

A new study suggests that daily taxifolin intake may support weight loss in older adults, possibly through brown fat activation and cholesterol regulation.

18 Feb 2025

From soy sauce to sodium labels: How Japan is rethinking salt reduction

Japan’s salt reduction efforts have lowered sodium intake over decades, but levels remain high, prompting economic modeling to assess the impact of stricter policies on cardiovascular disease and healthcare costs.

18 Feb 2025

New treatment cuts aggression in male offenders with antisocial personality disorder

A new psychological therapy designed by a team of UCL-led researchers has been found to reduce rates of violence and aggression among male offenders with antisocial personality disorder (ASPD).

18 Feb 2025

Cholesterol metabolite linked to Parkinson's disease development in mice

Researchers led by Zhentao Zhang at Wuhan University, China have discovered a cholesterol metabolite that plays a critical role in the development of Parkinson's disease in mice.

18 Feb 2025

Radiation and immunotherapy help preserve bladders in patients with muscle-invasive bladder cancer

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses that allowed for bladder preservation, according to results from the IMMUNOPRESERVE clinical trial.

18 Feb 2025